Bifogade filer
Kurs & Likviditet
Kalender
2025-02-27 | Bokslutskommuniké 2024 |
2024-11-28 | Kvartalsrapport 2024-Q3 |
2024-08-27 | Kvartalsrapport 2024-Q2 |
2024-06-20 | Ordinarie utdelning AXIC A 0.00 SEK |
2024-06-19 | Årsstämma 2024 |
2024-05-23 | Kvartalsrapport 2024-Q1 |
2024-03-06 | Extra Bolagsstämma 2024 |
2024-03-05 | Bokslutskommuniké 2023 |
2023-11-22 | Kvartalsrapport 2023-Q3 |
2023-08-23 | Kvartalsrapport 2023-Q2 |
2023-06-19 | Ordinarie utdelning AXIC A 0.00 SEK |
2023-06-16 | Årsstämma 2023 |
2023-05-24 | Kvartalsrapport 2023-Q1 |
2023-02-23 | Bokslutskommuniké 2022 |
2022-11-24 | Kvartalsrapport 2022-Q3 |
2022-08-25 | Kvartalsrapport 2022-Q2 |
2022-06-01 | Ordinarie utdelning AXIC A 0.00 SEK |
2022-05-31 | Årsstämma 2022 |
2022-05-24 | Kvartalsrapport 2022-Q1 |
2022-02-17 | Bokslutskommuniké 2021 |
2021-11-11 | Kvartalsrapport 2021-Q3 |
2021-08-31 | Kvartalsrapport 2021-Q2 |
2021-05-31 | Ordinarie utdelning AXIC A 0.00 SEK |
2021-05-28 | Årsstämma 2021 |
2021-05-20 | Kvartalsrapport 2021-Q1 |
2021-02-24 | Bokslutskommuniké 2020 |
2020-11-12 | Kvartalsrapport 2020-Q3 |
2020-08-21 | Kvartalsrapport 2020-Q2 |
2020-05-27 | Ordinarie utdelning AXIC A 0.00 SEK |
2020-05-26 | Årsstämma 2020 |
2020-05-14 | Kvartalsrapport 2020-Q1 |
2020-02-27 | Bokslutskommuniké 2019 |
2019-11-14 | Kvartalsrapport 2019-Q3 |
2019-08-29 | Kvartalsrapport 2019-Q2 |
2019-05-29 | Ordinarie utdelning AXIC A 0.00 SEK |
2019-05-28 | Årsstämma 2019 |
2019-05-23 | Kvartalsrapport 2019-Q1 |
2019-02-27 | Bokslutskommuniké 2018 |
2018-11-15 | Kvartalsrapport 2018-Q3 |
2018-08-29 | Kvartalsrapport 2018-Q2 |
2018-06-01 | Ordinarie utdelning AXIC A 0.00 SEK |
2018-05-31 | Årsstämma 2018 |
2018-05-15 | Kvartalsrapport 2018-Q1 |
2018-02-27 | Bokslutskommuniké 2017 |
2017-11-23 | Kvartalsrapport 2017-Q3 |
2017-08-24 | Kvartalsrapport 2017-Q2 |
2017-06-01 | Ordinarie utdelning AXIC A 0.00 SEK |
2017-05-31 | Årsstämma 2017 |
2017-05-31 | Kvartalsrapport 2017-Q1 |
2017-05-24 | Kvartalsrapport 2017-Q1 |
2017-02-23 | Bokslutskommuniké 2016 |
2016-11-24 | Kvartalsrapport 2016-Q3 |
2016-08-25 | Kvartalsrapport 2016-Q2 |
2016-05-24 | Ordinarie utdelning AXIC A 0.00 SEK |
2016-05-23 | Årsstämma 2016 |
2016-05-19 | Kvartalsrapport 2016-Q1 |
2016-02-25 | Bokslutskommuniké 2015 |
2015-11-25 | Kvartalsrapport 2015-Q3 |
2015-08-26 | Kvartalsrapport 2015-Q2 |
2015-05-29 | Ordinarie utdelning AXIC A 0.00 SEK |
2015-05-28 | Årsstämma 2015 |
2015-05-25 | Kvartalsrapport 2015-Q1 |
2015-02-26 | Bokslutskommuniké 2014 |
2014-11-24 | Kvartalsrapport 2014-Q3 |
2014-08-28 | Kvartalsrapport 2014-Q2 |
2014-05-22 | Årsstämma 2014 |
2014-05-22 | Kvartalsrapport 2014-Q1 |
2014-02-28 | Bokslutskommuniké 2013 |
2013-11-29 | Kvartalsrapport 2013-Q3 |
2013-08-26 | Kvartalsrapport 2013-Q2 |
2013-06-28 | Split AXIC A 4:1 |
2013-05-30 | Kvartalsrapport 2013-Q1 |
2013-05-21 | Ordinarie utdelning AXIC A 0.00 SEK |
2013-05-20 | Årsstämma 2013 |
2013-02-28 | Bokslutskommuniké 2012 |
2012-11-26 | Kvartalsrapport 2012-Q3 |
2012-08-30 | Kvartalsrapport 2012-Q2 |
2012-05-28 | Kvartalsrapport 2012-Q1 |
2012-05-17 | Ordinarie utdelning AXIC A 0.00 SEK |
2012-05-16 | Årsstämma 2012 |
2012-02-29 | Bokslutskommuniké 2011 |
2011-11-28 | Kvartalsrapport 2011-Q3 |
2011-08-30 | Kvartalsrapport 2011-Q2 |
2011-05-30 | Kvartalsrapport 2011-Q1 |
2011-05-10 | Ordinarie utdelning AXIC A 0.00 SEK |
2011-05-09 | Årsstämma 2011 |
2011-02-25 | Bokslutskommuniké 2010 |
2010-05-11 | Ordinarie utdelning AXIC A 0.00 SEK |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Material |
Industri | Plast, kemikalier & fetter |
aXichem AB (publ), a pioneer in the development and marketing of natural analogue industrial chemicals, is pleased to announce new orders for aXivite[®] from Uriach, a renowned and expanding European pharmaceutical company. The order is related to the production of a new melatonin formula for Uriach's brand Aquilea[®] featuring aXivite[®]. The first order was announced in November 2023, and with the additional orders placed, the total order value from Uriach, to date, amounts to about 60,000 Euro.
"We're delighted with this progress and eager to further develop our collaboration with Uriach on the Aquilea product with aXivite. This partnership offers valuable insights into phenylcapsaicin's role as a bio-enhancer and its market potential in health and wellness", says Torsten Helsing, CEO of aXichem.
The Supply and Research Agreement with Uriach, signed in June 2023, grants Uriach exclusive rights to a melatonin formulation with aXivite in Spain, Portugal, Germany, Austria, and Romania, with a commitment to an annual minimum purchase of 400,000 Euro. In April 2024 Spain will be the first market to experience Aquilea's new formula containing aXivite. The roll-out will then continue market by market, further expanding the reach and impact of aXivite in the dietary supplement market.
About phenylcapsaicin and aXivite
aXichem's proprietary molecule, phenylcapsaicin, combines the naturally occurring phenyl group with capsaicin, connected by a triple bond. The result is an innovative natural analog capsaicin with high purity, which in several studies has been shown to have the same health-promoting properties, as well as some unique benefits, as natural capsaicin. Phenylcapsaicin is approved under Novel Food in the EU and GRAS Food in the USA and is marketed for dietary supplements and functional foods under the brand name aXivite.
The information was submitted, through the care of the contact person below, for publication on 10 January 2024, at 09:30 CET.
Torsten Helsing, CEO, aXichem, Ph+46 70 686 33 55. Email: torsten.helsing@axichem.se